Healthcare Regulatory & Qui Tam Defense Insurance in Florida

Florida at a glance

State false claims statute

Florida False Claims Act, Fla. Stat. §68.081–092

Reaches false claims to any state agency, not only Medicaid.

Program integrity regulator

AHCA Bureau of Medicaid Program Integrity

Runs administrative audits and can suspend or terminate provider agreements.

State-specific kickback statute

Patient Brokering Act, Fla. Stat. §817.505

Criminalizes payment for patient referrals, heavily enforced in substance-abuse treatment.

Insurance regulator

Office of Insurance Regulation

Confirm current Florida licensing and filing guidance directly with the office.

Florida False Claims Act and qui tam procedure

Fla. Stat. §68.081 through §68.092 permits a private relator to file suit for the state, with the Department of Legal Affairs given a review period to intervene before the case can proceed publicly. Florida’s version reaches false claims submitted to any state agency, not just Medicaid, so a hospital system with state grant funding or state employee health-plan business can face exposure outside the Medicaid program itself.

AHCA program integrity and the Medicaid Fraud Control Unit

The Agency for Health Care Administration runs its own Bureau of Medicaid Program Integrity, which audits billing patterns and can suspend or terminate provider agreements administratively, while the Attorney General’s Medicaid Fraud Control Unit pursues civil recoveries and criminal cases for patient abuse or neglect in Medicaid facilities. These two tracks run on different timelines and can each demand records from the same event.

Patient brokering exposure specific to Florida

Florida’s Patient Brokering Act, Fla. Stat. §817.505, criminalizes paying or receiving anything of value for referrals of patients, a statute enforced heavily against substance-abuse treatment and sober-home referral arrangements statewide. This is a state-specific overlay on top of the federal Anti-Kickback Statute, and it has produced criminal charges in Florida where a comparable arrangement elsewhere might only draw civil scrutiny.

Program-integrity posture across Florida’s hospital networks

With large hospital networks and research centers concentrated in South Florida, Tampa Bay, and Orlando, cross-entity referral relationships and telehealth expansion since 2020 have both drawn AHCA attention. Regular exclusion screening, a documented overpayment self-disclosure process, and marketing-and-referral compliance review reduce the odds that a routine audit becomes a relator complaint.

Building a defense-focused program

Coverage discussions should focus on defense costs for civil investigative demands, AHCA administrative proceedings, and licensing board matters, since restitution, fines, and intentional-conduct penalties are not insurable. Confirm the current scope of the Patient Brokering Act and any recent AHCA rule changes with counsel before finalizing terms.

Who we write this for in Florida

Healthcare regulatory defense FAQs for Florida